Taken together, these proof-of-concept experiments showed that postnatal inhibition of FLT1 by anti-FLT1 peptide could ameliorate the pathology associated with DMD in the mdx mice. This evidence concerns the gene FLT1 and Duchenne muscular dystrophy.